TRICARE Formulary Drug List Reviewed

Week of September 14, 2009

The Beneficiary Advisory Panel (BAP) met recently to provide comments on the Department of Defense (DoD) Pharmacy and Therapeutics Committee's recommendations on formulary status, pre-authorizations, and the effective date for a drug's change from formulary to non-formulary status. Moving a drug to non-formulary status means it will still be available to beneficiaries, but usually at a higher price. It may also require additional medical authorization. The BAP reviewed both current and new drugs. For a complete list of formulary medications, visit the TRICARE Formulary Search Tool webpage. For additional information on this or other BAP meetings, visit the DoD Uniform Formulary Beneficiary Advisory Panel site.

Military.com surveys have found that most servicemembers and their families are confused by TRICARE. Get the facts and latest news on TRICARE.